Literature DB >> 22189817

Relation between right and left ventricular function in patients undergoing chronic dialysis.

Francesco Paneni1, Mario Gregori, Giuseppino M Ciavarella, Sebastiano Sciarretta, Francesca Palano, Giulia Pignatelli, Lorenzo Castello, Alessandro Domenici, Giorgio Punzo, Giuliano Tocci, Luciano De Biase, Paolo Menè, Massimo Volpe.   

Abstract

AIMS: Occurrence of heart failure during dialysis treatment is associated with high mortality. However, mechanisms underlying left ventricular dysfunction (LVD) in these patients are still elusive. In patients undergoing haemodialysis, arteriovenous fistula (AVF) is associated with right ventricular dysfunction (RVD) and a further impairment is observed when AVF is brachial rather than radial. However, it is not known whether AVF-induced RVD is associated with an impaired left ventricular function. We studied the relation between right and left ventricular function in 120 patients undergoing either haemodialysis or peritoneal dialysis and 100 healthy age-matched controls.
METHODS: Echocardiography including tissue Doppler imaging (TDI) was performed for both ventricles. Average myocardial performance index (MPI) of the right ventricle (RV MPI) was obtained with a multisegmental approach by using TDI.
RESULTS: RVD was higher in haemodialysis than peritoneal dialysis patients and a further increase was observed in haemodialysis patients with brachial access. Interestingly, RV MPI inversely correlated with indices of both left ventricular contraction and relaxation and the association was even stronger in haemodialysis patients, particularly in those with brachial AVF. Of note, dialysis patients in the upper tertile of RV MPI showed the larger impairment of left ventricular function. Regression analyses showed that RV MPI was independently associated with reduced left ventricular function. By contrast, LVD did not significantly affect right ventricular performance in this setting.
CONCLUSION: AVF-induced RVD may contribute to LVD in dialysis patients. AVF plays a pivotal role in triggering LVD via right-to-left ventricular interdependence.

Entities:  

Mesh:

Year:  2013        PMID: 22189817     DOI: 10.2459/JCM.0b013e32834eacf0

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  5 in total

1.  The effects of frequent hemodialysis on left ventricular mass, volumes, and geometry.

Authors:  Rakesh K Mishra; Ruth F Dubin
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

2.  Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.

Authors:  LaTonya J Hickson; Sara M Negrotto; Macaulay Onuigbo; Christopher G Scott; Andrew D Rule; Suzanne M Norby; Robert C Albright; Edward T Casey; John J Dillon; Patricia A Pellikka; Sorin V Pislaru; Patricia J M Best; Hector R Villarraga; Grace Lin; Amy W Williams; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2016-03-15       Impact factor: 24.094

3.  Inadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction.

Authors:  Mario Gregori; Giuliano Tocci; Andrea Marra; Giulia Pignatelli; Caterina Santolamazza; Alberto Befani; Giuseppino Massimo Ciavarella; Andrea Ferrucci; Francesco Paneni
Journal:  Clin Res Cardiol       Date:  2013-06-14       Impact factor: 5.460

4.  Changes of Left and Right Ventricle Mechanics and Function in Patients with End-Stage Renal Disease Undergoing Haemodialysis.

Authors:  Eglė Tamulėnaitė; Rūta Žvirblytė; Rūta Ereminienė; Edita Žiginskienė; Eglė Ereminienė
Journal:  Medicina (Kaunas)       Date:  2018-11-13       Impact factor: 2.430

5.  Pathological right ventricular changes in synthesized electrocardiogram in end-stage renal disease patients and their association with mortality and cardiac hospitalization: a cohort study.

Authors:  Yunis Daralammouri; Jamal Qaddumi; Khubaib Ayoub; Doaa Abu-Hantash; Mai Arafat Al-Sadi; Rofayda M Ayaseh; Murad Azamtta; Osama Sawalmeh; Zakaria Hamdan
Journal:  BMC Nephrol       Date:  2022-02-24       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.